Hospira Recalls Quelicin Injection Due to Faded or Missing Label Dates
Hospira Inc. is recalling 103,600 vials of Quelicin (Succinylcholine Chloride) Injection because the lot number or expiration date may be faded or missing from the primary label.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The hazard is limited to a labeling defect (faded or missing dates) without reported injuries or illnesses.
Plain-English summary
Hospira Inc. is recalling 103,600 vials of Quelicin (Succinylcholine Chloride) Injection, USP 200 mg (20 mg/mL), 10 mL Multiple-dose vial. The product is distributed nationwide and is identified by Lot 52-045-EV with an expiration date of 07/1/2016.
The recall was initiated due to a labeling defect where the lot number and/or expiration date may be faded or missing from the primary label on the glass vial. This issue could potentially affect the ability to verify the specific lot and expiration status of the medication.
Healthcare providers and facilities should check their inventory for this specific lot and expiration date. If the product is found, it should be removed from use and returned to Hospira Inc. according to their instructions.
The recalled product
- Product
- QUELICIN (SUCCINYLCHOLINE CHLORIDE)
- Brand
- QUELICIN
- Manufacturer
- Hospira Inc.
- Category
- Drug — Injection
- Hazard
- Affected units
- 103,600
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot 52-045-EV
- Exp 07/1/2016
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · QUELICIN
- SevereHospira Recalls Quelicin Injection Due to Lack of Sterility Assurance
FDA (Drugs) · 2017-08-09
- SevereHospira Recalls QUELICIN Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-15
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recalled for White Screen Shutdown
FDA (Devices) · 2016-11-16
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereHospira Recalls Quelicin Injection Due to Lack of Sterility Assurance
FDA (Drugs) · 2017-08-09
- SevereHospira Recalls QUELICIN Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-15
- LowHospira Recalls Vancomycin Hydrochloride Vials Due to Mislabeling
FDA (Drugs) · 2014-11-26
- SevereHospira Recalls Sodium Chloride Injection Vials Due to Particulate Matter
FDA (Drugs) · 2013-07-31
- ModerateHospira Recalls Ketamine Hydrochloride Injection Due to Cracked Vials
FDA (Drugs) · 2015-09-23
- SevereAdvanced Pharma Recalls Succinylcholine Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2017-07-19